| P50 | author | Janke Schinkel | Q28051246 |
| | Lisa Maher | Q67328594 |
| | Margaret E Hellard | Q85903750 |
| | Gregory J Dore | Q90411646 |
| | Naglaa H Shoukry | Q91483136 |
| | Chaturaka Rodrigo | Q37381705 |
| | Homie Razavi | Q37391777 |
| | Auda A. Eltahla | Q39403960 |
| | Andrew R. Lloyd | Q44958229 |
| | Jason Grebely | Q45328571 |
| | Rowena A Bull | Q56400255 |
| | Tanya Applegate | Q58691432 |
| | Georg M Lauer | Q60976715 |
| P2093 | author name string | Fabio Luciani | |
| | Arthur Y Kim | |
| | Julie Bruneau | |
| | Kimberly Page | |
| | William Osburn | |
| | Maria Prins | |
| | Andrea L Cox | |
| | Meghan D Morris | |
| | Chris Estes | |
| | International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) Study Group | |
| P2860 | cites work | The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis | Q21563395 |
| | Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak | Q23000449 |
| | Genetic history of hepatitis C virus in East Asia | Q24655361 |
| | Burden of disease and cost of chronic hepatitis C infection in Canada | Q26849591 |
| | Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages | Q27329614 |
| | A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades | Q27473000 |
| | Emergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological Profiles | Q27490460 |
| | BEAST: Bayesian evolutionary analysis by sampling trees | Q27860723 |
| | The injection century: massive unsterile injections and the emergence of human pathogens | Q28211765 |
| | Bayesian coalescent inference of past population dynamics from molecular sequences | Q28306728 |
| | Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e | Q28655567 |
| | MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences | Q29617490 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource | Q33777199 |
| | The mode and tempo of hepatitis C virus evolution within and among hosts | Q33905948 |
| | Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study | Q86945719 |
| | The history of blood transfusion | Q33923279 |
| | The epidemic behavior of the hepatitis C virus | Q33952875 |
| | Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa | Q34172845 |
| | Global distribution and prevalence of hepatitis C virus genotypes | Q34431175 |
| | The genetic diversity and evolutionary history of hepatitis C virus in Vietnam | Q34615527 |
| | The evolutionary rates of HCV estimated with subtype 1a and 1b sequences over the ORF length and in different genomic regions | Q34769441 |
| | A method for near full-length amplification and sequencing for six hepatitis C virus genotypes | Q35961789 |
| | Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 | Q36035889 |
| | Chronic hepatitis C virus (HCV) disease burden and cost in the United States | Q37148328 |
| | Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. | Q37460833 |
| | The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study | Q37594232 |
| | Epidemiology and natural history of HCV infection. | Q38118578 |
| | Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia | Q38233245 |
| | The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm | Q39213684 |
| | Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study. | Q39221144 |
| | Phylogenetic analysis of the emergence of main hepatitis C virus subtypes in São Paulo, Brazil | Q39305646 |
| | HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006. | Q39880574 |
| | Identification of Indian sub-continent as hotspot for HCV genotype 3a origin by Bayesian evolutionary reconstruction. | Q41738153 |
| | Tracing the spread of hepatitis C virus in Turkey: a phylogenetic analysis | Q42268423 |
| | Epidemic history of Hepatitis C virus in Brazil | Q42998844 |
| | Narcotic use in southeast Asia and afterward. An interview study of 898 Vietnam returnees | Q43787879 |
| | Modelling and calibration of the hepatitis C epidemic in Australia. | Q45965007 |
| | Injection drug users in the United States, 1979-2002: an aging population | Q48627430 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Australia | Q408 |
| | hepatitis C | Q154869 |
| | Hepatitis C virus | Q708693 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1383-1389 | |
| P577 | publication date | 2016-08-28 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia | |
| P478 | volume | 214 | |